论文信息 - Effects of hydroxyurea on F‐cells in sickle cell disease and potential impact of a second fetal globin inducer - 字舞流文

Effects of hydroxyurea on F‐cells in sickle cell disease and potential impact of a second fetal globin inducer

S. Nekhai | J. Sangerman | Yan Dai | M. Nouraie | S. Perrine | M. Steinberg | P. Oneal | O. Owoyemi | X. Niu | R. Taylor | A. Rock | Aidan D. Faller | D. Maharaj | Shauiying Cui

[1] J. Makani,et al. High prevalence of individuals with low concentration of fetal hemoglobin in F‐cells in sickle cell anemia in Tanzania , 2016, American journal of hematology.

[2] B. Pace,et al. Targeted fetal hemoglobin induction for treatment of beta hemoglobinopathies. , 2014, Hematology/oncology clinics of North America.

[3] Paola Sebastiani,et al. Fetal hemoglobin in sickle cell anemia: a glass half full? , 2013, Blood.

[4] K. Ataga,et al. The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐up , 2010, American journal of hematology.

[5] Clinton H Joiner,et al. The effect of fetal hemoglobin on the survival characteristics of sickle cells. , 2006, Blood.

[6] S. Antonarakis,et al. Production of F cells in sickle cell anemia: regulation by a genetic locus or loci separate from the beta-globin gene cluster. , 1984, Blood.